OGDEN CHRISTOPHER (See Remarks) sold 5.1% of their position (12.26K shares) of CYTOMX THERAPEUTICS, INC. on the open market
Open‑market sale worth $33.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/17/2025ACC: 0001610717-25-000236
Officer· See Remarks
Since Feb 2022
-12.26K
Net shares
Net seller
$33.4K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
37.50K acquired · 49.76K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.64K
Price / share
$2.95
Trade value
$4.84K
% of position
0.8%
6/13/2025
201.03K→199.38K
Common Stock
Direct
Shares
+37.50K
Price / share
—
Trade value
—
% of position
18.8%
6/13/2025
199.38K→236.88K
Common Stock
Direct
Shares
−10.61K
Price / share
$2.69
Trade value
$28.54K
% of position
4.5%
6/16/2025
236.88K→226.27K
Total
Net shares
+25.25K
Net value
-$33.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2025 | S · Sale | −1.64K | $2.95 | $4.84K | 0.8% | 201.03K | 199.38K |
| Common Stock Direct | 6/13/2025 | M · Option Exercise | +37.50K | — | — | 18.8% | 199.38K | 236.88K |
| Common Stock Direct | 6/16/2025 | S · Sale | −10.61K | $2.69 | $28.54K | 4.5% | 236.88K | 226.27K |
| Total | +25.25K | -$33.38K | ||||||
Derivative Transactions1
Performance Stock Units
Direct
Converts to
Common Stock
37.50K shares
Shares
−37.50K
Strike price
Held after
0.00
Exercisable
—
6/13/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock37.50K shares | 6/13/2025 | M · Option Exercise | −37.50K | — | 0.00 |